Coronary Urate Detected by Spectral CT Marks the Vulnerable Plaque
This study demonstrates that spectral CT can detect coronary urate deposits within plaques, identifying them as a unique, independent predictor of high-risk vulnerable plaque driven by local crystal-induced inflammation, even in patients with normal serum urate levels.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For decades, doctors have watched the levels of a substance called urate in the blood, hoping it would reveal who is at risk for a heart attack. High levels are often seen in people with gout, a painful form of arthritis, and they have long been linked to heart trouble. Yet, when researchers tried to lower these blood levels to protect the heart, the treatments failed to prevent heart attacks. This created a confusing puzzle: if the blood level matters, why does changing it do nothing? The missing piece of the story may be that the danger does not come from the urate floating in the bloodstream at all, but from tiny crystals that form silently inside the walls of the arteries themselves. These crystals, made of a substance called monosodium urate, act like a spark that ignites inflammation within a plaque, making it unstable and likely to rupture. Until now, these crystals have been invisible to standard medical scans, hiding in plain sight while the blood tests gave a false sense of security.
A team of researchers from Japan, the United States, Hungary, and Canada has now found a way to see these hidden crystals and has shown that they are a powerful warning sign of a dangerous heart condition. Using a special type of CT scanner that can distinguish between different materials based on their atomic structure, the scientists looked at the coronary arteries of 116 patients. These machines, known as dual-energy CT scanners, can tell the difference between calcium, which is common in hardened arteries, and urate crystals, which are chemically distinct. In the study, the researchers found that nearly one in three patients had these urate crystals sitting inside their artery walls, even though most of these patients had normal levels of urate in their blood and no history of gout. The presence of these crystals was the only factor that consistently predicted the presence of a "high-risk plaque," a specific type of soft, unstable buildup that is most likely to cause a heart attack. In contrast, the amount of calcium in the arteries, which is usually the main thing doctors look for, did not predict this danger on its own.
To make sure this discovery was real and not just a result of the computer software, the team repeated the search using a completely different technology called photon-counting CT, which counts individual particles of light. In a separate group of 92 patients, this new machine also found the same urate crystals in the arteries, confirming that the signal was genuine. The researchers then took a closer look at actual human heart tissue obtained from autopsies. Using a high-powered microscope that uses polarized light, they saw needle-shaped crystals that matched the signature of urate. They also mapped the cells responsible for making these crystals. They found that a specific type of immune cell, known as a macrophage, which gathers at the edge of the soft, fatty core of a plaque, produces an enzyme that creates urate. As the plaque grows and becomes more dangerous, these cells become more active, generating more crystals right where the artery is most likely to break open.
The findings suggest that the problem is not the amount of urate in the blood, but the local production of crystals inside the artery wall. The blood tests failed in the past because they were measuring the wrong pool of urate; the dangerous stuff is trapped inside the plaque, generated by the cells there, and has nothing to do with the circulating levels. This discovery changes how we might think about treating heart disease. Instead of trying to lower the blood level of urate, which has not worked, doctors might one day use these scans to find patients who have these specific crystals and treat the inflammation directly at the site of the plaque. The study shows that a simple, non-invasive scan can now spot a crystal-driven fire that was previously invisible, offering a new way to identify who is truly at risk and perhaps a new target for therapy to stop the heart attack before it happens.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.